Tamoxifen Citrate
Tamoxifen Citrate is a nonsteroidal agent which has demonstrated potent antiestrogenic properties in animal test systems. The antiestrogenic effects may be related to its ability to compete with estrogen for binding sites in target tissues such as breast. Tamoxifen inhibits the induction of rat mammary carcinoma induced by dimethylbezanthracene (DMBA) and causes the regression of already established DMBA-induced tumors. In this rat model, tamoxifen appears to exert its antitumor effects by binding the estrogen receptors. It is also recognized that tamoxifen displays estrogenic like effects on several sites including the endometrium, bone and lipids.
Product Details
| Category |
Bone Disease & Osteoporosis Cancer Research and Antivirals |
|---|---|
| Price | POA |
| CAS Number | 54965-24-1 |
| Formula | C26H29NO · C6H8O7 |
| Molecular Weight | 563.64 |
| Purity | 99.0% |
| Appearance | white solid powder |
| Availability | In Stock |
| Storage Conditions | +4°C |
Product Enquiry
Send us your enquiry for Tamoxifen Citrate. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Tamoxifen Citrate email us and we will include your contribution on the website.
